Home/Filings/4/0001209191-14-001838
4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-001838

CIK 0001009356operating

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:37 PM ET

Size

7.3 KB

Accession

0001209191-14-001838

Insider Transaction Report

Form 4
Period: 2014-01-02
DERBYSHIRE ADAM C
EVP Finance/CFO
Transactions
  • Tax Payment

    Common Stock

    2014-01-02$89.94/sh9,135$821,602179,395 total
Holdings
  • Option to Buy Common Stock

    Exercise: $18.87Exp: 2014-06-17Common Stock (30,000 underlying)
    30,000
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (20,000 underlying)
    20,000
Footnotes (2)
  • [F1]Does not represent a sale in the market; represents a forfeiture of shares to the Issuer in order to pay tax withholding upon vesting of restricted stock.
  • [F2]Options are 100% vested.

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001009356

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:37 PM ET
Size
7.3 KB